Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring

Launched by MAYO CLINIC · Mar 11, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at a new type of breast ultrasound to see how well it can detect breast cancer and monitor how well treatment is working. The study aims to improve the way doctors find and diagnose breast abnormalities, especially for patients who have already been diagnosed or are undergoing treatment. By using this advanced ultrasound method, researchers hope to better understand changes in the breast as patients receive therapy.

To participate in the trial, you need to be at least 18 years old and either have a suspicious breast mass that requires a biopsy or have already been diagnosed with breast cancer and are receiving treatment. However, if you have breast implants or a condition that would make it hard to use the ultrasound, you won't be eligible. If you join the study, you can expect to undergo this new ultrasound procedure and help contribute to important research that could improve breast cancer detection and treatment monitoring in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • AIM 1: Patient volunteers, ages \>= 18 with suspicious breast masses scheduled for breast biopsy, or at least two weeks or more after breast biopsy
• • AIM 2: Patient volunteers, ages \>= 18 who have biopsy proven breast cancer and are going under neoadjuvant chemotherapy and/or endocrine therapy had their baseline MRI and/or ultrasound
• Exclusion Criteria:
• • Patients with breast implants or any condition that does not allow proper use of ultrasound (US)